The dorsomedial prefrontal cortex plays a critical role in mapping out personal actions and outcomes as well as responding to the actions of others.
Irisin, a hormone secreted by muscles during exercise, improved cognitive function and lowered levels of inflammation in mouse models. The findings have implications for the development of treatments for Alzheimer's and other neurodegenerative diseases.
Mouse and human studies reveal Interleukin-3 may modify immune responses in the brain that cause cell death and lead to Alzheimer's disease.
The structure of SuperAgers' brains and the connectivity of their neural networks more closely resembles the brains of younger adults, a neuroimaging study reveals.
Higher levels of two cytokines were associated with slower cognitive decline in aging adults, a new study reports.
Animal studies and analysis of human data reveal a link between vitamin D deficiency and an increased risk of both opioid addiction and sun-seeking behaviors.
Sevoflurane, an anesthetic, causes tau to leave neurons and enter microglia. This stimulates the production of interleukin-6, leading to inflammation and cognitive impairment.
Combining αGITR antibodies with ICBs resulted in stronger survival benefits in mouse models of human glioblastoma brain cancer.
A number of videos have surfaced on popular channels showing people experiencing some adverse effects following the coronavirus vaccine. Researchers say some of the cases could be related to functional neurological disorder, a common neuropsychological condition.
A new whole-genome sequencing study has revealed thirteen novel genes associated with Alzheimer's disease. Researchers also found a new link between Alzheimer's and synaptic function.
Researchers found that while there are genetic overlaps between the sexes in relation to mental health disorders, there are also sex-specific differences in how genes related to the immune system, central nervous system, and blood vessels affect people with mental health problems.
A new genetic engineering strategy significantly reduces levels of tau in animal models of Alzheimer's disease. The treatment, which involves a single injection, appears to have long-last effects.
